Delineation of a Conserved Arrestin-Biased Signaling Repertoire In Vivo

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmacology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.114.095224PMID 25637603PMCID PMC4366796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

  2014cited by this paper
• Conserved abundance and topological features in chromatin‐remodeling protein interaction networks

  2014cited by this paper
• Systems analysis of arrestin pathway functions.

  2013cited by this paper
• Extracting insights from the shape of complex data using topology

  2013cited by this paper
• β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.

  2013cited by this paper
• Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.

  2013cited by this paper
• Plurigon: three dimensional visualization and classification of high-dimensionality data

  2013cited by this paper
• Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171–82Q Model of Huntington Disease Is Related to Their Physiological Efficacy*

  2012cited by this paper
• β-Arrestin2 mediates the initiation and progression of myeloid leukemia

  2012cited by this paper
• Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR

  2012cited by this paper
• VENNTURE–A Novel Venn Diagram Investigational Tool for Multiple Pharmacological Dataset Analysis

  2012cited by this paper
• Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics.

  2012cited by this paper
• Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling

  2012cited by this paper
• Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

  2012influential reference
• Elevated b-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia

  2011cited by this paper
• Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia

  2011cited by this paper
• Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival

  2011cited by this paper
• Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.

  2011cited by this paper
• The β-Arrestin Pathway-selective Type 1A Angiotensin Receptor (AT1A) Agonist [Sar1,Ile4,Ile8]Angiotensin II Regulates a Robust G Protein-independent Signaling Network*

  2011cited by this paper
• Therapeutic potential of β-arrestin- and G protein-biased agonists.

  2011cited by this paper
• β-Arrestin-mediated receptor trafficking and signal transduction.

  2011cited by this paper
• Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling

  2010cited by this paper
• Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

  2010cited by this paper
• Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists*

  2010cited by this paper
• Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses

  2010cited by this paper
• β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor Cells

  2009cited by this paper
• β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis

  2009cited by this paper
• A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation

  2009cited by this paper
• Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer

  2009cited by this paper
• Topology and data

  2009cited by this paper
• The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development.

  2009cited by this paper
• Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis.

  2008cited by this paper
• Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?

  2007cited by this paper
• Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation*

  2006cited by this paper
• Role of β-arrestin 1 in the metastatic progression of colorectal cancer

  2006cited by this paper
• Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

  2006cited by this paper
• Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy

  2006cited by this paper
• Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways.

  2006cited by this paper
• - Arrestin-and G Protein Receptor Kinase-Mediated Calcium-Sensing Receptor Desensitization

  2005cited by this paper
• The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling

  2005cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.

  2003cited by this paper
• Na+/H+ exchanger-regulatory factor 1 mediates inhibition of phosphate transport by parathyroid hormone and second messengers by acting at multiple sites in opossum kidney cells.

  2003cited by this paper
• Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2

  2003cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling

  2002cited by this paper
• Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

  1999cited by this paper
• Enhanced morphine analgesia in mice lacking beta-arrestin 2.

  1999cited by this paper
• Collective dynamics of ‘small-world’ networks

  1998cited by this paper
• Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

  1995cited by this paper
• Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues.

  1993cited by this paper

• G protein-coupled receptor digital twins for precision and personalized medicine

  2025cites this paper
• GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process

  2023cites this paper
• Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process

  2022cites this paper
• GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease

  2021influential citation
• Systems Pharmacology: Enabling Multidimensional Therapeutics

  2021cites this paper
• Aging-related modifications to G protein-coupled receptor signaling diversity.

  2020cites this paper
• A cellular perspective of bias at G protein‐coupled receptors

  2020cites this paper
• Multi-functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms

  2019cites this paper
• G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence

  2019cites this paper
• Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics.

  2019cites this paper
• Biased Receptor Signaling in Drug Discovery

  2019cites this paper
• High-dimensionality Data Analysis of Pharmacological Systems Associated with Complex Diseases

  2019influential citation
• The RXFP3 receptor is functionally associated with cellular responses to oxidative stress and DNA damage

  2019cites this paper
• Multidimensional informatic deconvolution defines gender-specific roles of hypothalamic GIT2 in aging trajectories.

  2019cites this paper
• Psychiatric Disorders: Methods and Protocols

  2019cites this paper
• β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders

  2018cites this paper
• Intelligent and effective informatic deconvolution of “Big Data” and its future impact on the quantitative nature of neurodegenerative disease therapy

  2018influential citation
• Translating in vitro ligand bias into in vivo efficacy.

  2018cites this paper
• G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes

  2018cites this paper
• Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?

  2018cites this paper
• Measuring G protein‐coupled receptor signalling in the brain with resonance energy transfer based biosensors

  2017cites this paper
• Is Signaling Specificity Encoded in Arrestin Conformation

  2017cites this paper
• Running Title: Climate change in GPCR drug discovery?

  2017cites this paper
• G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands

  2017cites this paper
• Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.

  2017cites this paper
• The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling

  2017cites this paper
• Retromer stops beta-arrestin 1–mediated signaling from internalized cannabinoid 2 receptors

  2017cites this paper
• Biasing the odds: Approaches to capturing, understanding and exploiting functional selectivity in GPCRs.

  2016cites this paper
• Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues*

  2016cites this paper
• Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.

  2016cites this paper
• Mechanisms of Biased b-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor s

  2016cites this paper
• The Multiple Waves of Cannabinoid 1 Receptor Signaling

  2016cites this paper
• Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor

  2016cites this paper
• GPCR endocytosis confers uniformity in responses to chemically distinct ligands

  2016cites this paper
• Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics.

  2016cites this paper
• Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity

  2015cites this paper
• Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism

  2015influential citation
• New paradigms in GPCR drug discovery.

  2015cites this paper